Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 08 04:00PM ET
19.02
Dollar change
+0.38
Percentage change
2.04
%
IndexRUT P/E- EPS (ttm)-3.54 Insider Own31.18% Shs Outstand41.21M Perf Week4.11%
Market Cap873.02M Forward P/E- EPS next Y-4.55 Insider Trans2.01% Shs Float31.59M Perf Month-10.87%
Income-147.71M PEG- EPS next Q-1.11 Inst Own74.46% Short Float13.20% Perf Quarter14.58%
Sales0.00M P/S- EPS this Y74.87% Inst Trans21.22% Short Ratio12.87 Perf Half Y-10.37%
Book/sh9.51 P/B2.00 EPS next Y-9.63% ROA- Short Interest4.17M Perf Year-
Cash/sh9.66 P/C1.97 EPS next 5Y- ROE- 52W Range13.14 - 33.92 Perf YTD-17.84%
Dividend Est.- P/FCF- EPS past 5Y- ROI-31.86% 52W High-43.93% Beta-
Dividend TTM- Quick Ratio16.96 Sales past 5Y0.00% Gross Margin- 52W Low44.75% ATR (14)1.28
Dividend Ex-Date- Current Ratio16.96 EPS Y/Y TTM- Oper. Margin0.00% RSI (14)49.02 Volatility4.94% 6.97%
Employees- Debt/Eq0.06 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price31.50
Option/ShortNo / Yes LT Debt/Eq0.06 EPS Q/Q-187.82% Payout- Rel Volume0.57 Prev Close18.64
Sales Surprise- EPS Surprise-1.56% Sales Q/Q- EarningsAug 12 AMC Avg Volume323.82K Price19.02
SMA20-6.56% SMA503.73% SMA200-5.85% Trades Volume184,045 Change2.04%
Date Action Analyst Rating Change Price Target Change
Jul-22-24Initiated H.C. Wainwright Buy $33
Jul-08-24Initiated Chardan Capital Markets Buy $28
Jun-27-24Initiated Piper Sandler Overweight $37
Dec-05-23Initiated Truist Buy $34
Dec-05-23Initiated TD Cowen Outperform
Dec-05-23Initiated JP Morgan Overweight $23
Dec-05-23Initiated Jefferies Buy $28
Aug-16-24 08:53PM
06:50PM
Aug-12-24 04:05PM
Jul-10-24 08:00AM
Jun-04-24 04:05PM
01:56PM Loading…
01:56PM
May-30-24 06:00AM
May-28-24 08:05AM
08:00AM
May-22-24 12:00PM
09:55AM
May-14-24 09:54PM
04:05PM
Apr-15-24 04:05PM
Mar-21-24 10:53PM
04:05PM Loading…
04:05PM
Feb-29-24 04:01PM
Jan-03-24 08:05AM
Dec-18-23 04:04PM
Dec-13-23 10:51PM
04:05PM
Dec-11-23 07:53PM
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy. The company was founded by Crystal Mackall, Nancy Goodman, Louai Labanieh, and Robbie Majzner in December 2019 and is headquartered in San Carlos, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chapman GinaPresident & CEOSep 18 '24Option Exercise5.037,16636,045111,071Sep 20 05:24 PM
Chapman GinaPresident & CEOSep 19 '24Option Exercise5.032,97514,964106,880Sep 20 05:24 PM
Chapman GinaPresident & CEOSep 18 '24Sale25.097,166179,775103,905Sep 20 05:24 PM
Chapman GinaPresident & CEOSep 19 '24Sale25.032,97574,457103,905Sep 20 05:24 PM
Radhakrishnan AnupChief Financial OfficerSep 18 '24Option Exercise5.031,6008,0488,046Sep 20 05:23 PM
Radhakrishnan AnupChief Financial OfficerSep 18 '24Sale25.281,60040,4526,446Sep 20 05:23 PM
ANUP RADHAKRISHNANOfficerSep 18 '24Proposed Sale23.3314,000326,620Sep 18 04:38 PM
GINA CHAPMANDirectorSep 18 '24Proposed Sale23.3375,0001,749,750Sep 18 04:36 PM
Samsara BioCapital GP, LLC10% OwnerMay 30 '24Buy17.00294,0004,998,0004,415,689Jun 03 09:45 PM
Samsara BioCapital GP, LLC10% OwnerNov 14 '23Buy15.00666,6669,999,9904,121,689Nov 16 07:39 PM
Third Rock Ventures V, L.P.10% OwnerNov 14 '23Buy15.001,333,33319,999,9951,807,119Nov 14 07:08 PM
PERCEPTIVE ADVISORS LLCFormer 10% OwnerNov 14 '23Buy15.00666,6669,999,9902,912,835Nov 14 04:32 PM